โ† All deals

SI-BONE, INC.

Public Equity (NASDAQ)Medical DevicePublic CompanyB2B
๐Ÿ“ Santa Clara, California, United Statesโ€ข Founded 2008
StreetZero Signal 52
Be the first to signal interest

About SI-BONE, INC.

SI-BONE, Inc. is a publicly traded medical device company focused on developing solutions for musculoskeletal disorders of the sacropelvic anatomy. Founded in 2008 and headquartered in Santa Clara, California, the company operates on a B2B model and is listed on NASDAQ under the symbol SIBN. It has completed multiple funding rounds totaling over $225 million, including a Post-IPO Equity round in 2023.

LATEST FUNDINGRule 144
$45K
Announced 2026-11-17
TOTAL RAISED$225.12M
๐Ÿ”’

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for SI-BONE, INC..

Free plan includes 3 full deal profiles every month.

EMPLOYEESโ€”
FOUNDED2008
HQSanta Clara, California, United States
Industry
Public Equity (NASDAQ)
Tags
Medical DevicePublic CompanyB2B

Key highlights

  • Completed Post-IPO Equity round of $77M in May 2023.
  • Went public via IPO on NASDAQ under ticker SIBN.
  • Total funding exceeds $225M from institutional investors including OrbiMed and Novo Holdings.
  • Focuses on sacropelvic musculoskeletal medical devices.

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.

Sign in to view the filing Create free account